Bonnie Hill

About

Bonnie Hill is a PCC, Trainer, Mentor Coach, and Leadership Development Executive Coach who is passionate about her work as an executive coach and trainer. She specializes in leadership development and has extensive experience supporting leaders in increasing organizational competencies, achieving organizational results, and leading with impact. Her clients have included senior executives, political appointees, and leaders in various government agencies such as HUD, USDA Forest Service, General Service Administration, HHS, Department of Education, NSA, Department of Defense, Army, and FDA. Additionally, she has worked with clients in hospitals, including Children’s National Medical Center in D.C., in industry such as Best Buy, and in non-profit organizations like MercyCorps and FHI360.

Research topics

• Psychology
• Medicine
• Clinical psychology
• Psychiatry
• Cognitive psychology

Selected publications

• Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project

  Journal of Alzheimer s Disease · 2022-07-04 · 67 citations

  articleOpen access

  BACKGROUND: Effective therapeutics for Alzheimer's disease are needed. However, previous clinical trials have pre-determined a single treatment modality, such as a drug candidate or therapeutic procedure, which may be unrelated to the primary drivers of the neurodegenerative process. Therefore, increasing data set size to include the potential contributors to cognitive decline for each patient, and addressing the identified potential contributors, may represent a more effective strategy. OBJECTI…

  PublisherOA PDFDOI

• Neuropsychological Functioning in Primary Dystonia: Updated and Expanded <scp>Multidomain Meta‐Analysis</scp>

  Movement Disorders · 2022-04-06 · 14 citations

  reviewSenior author

  Abstract Background Primary dystonia is conventionally considered as a motor disorder, though an emerging literature reports associated cognitive dysfunction. Objectives Here, we conducted meta‐analyses on studies comparing clinical measures of cognition in persons with primary dystonia and healthy controls (HCs). Methods We searched PubMed, Embase, Cochrane Library, Scopus, and PsycINFO (January 2000–October 2020). Analyses were modeled under random effects. We used Hedge's g as a bias‐correcte…

  PublisherDOI

• An examination of the relationship among plasma brain derived neurotropic factor, peripheral vascular function, and body composition with cognition in midlife African Americans/Black individuals

  Frontiers in Aging Neuroscience · 2022-08-25 · 11 citations

  articleOpen access

  African American/Black individuals have been excluded from several lines of prominent neuroscience research, despite exhibiting disproportionately higher risk factors associated with the onset and magnitude of neurodegeneration. Therefore, the objective of the current investigation was to examine potential relationships among brain derived neurotropic factor (BDNF), peripheral vascular function, and body composition with cognition in a sample of midlife, African American/Black individuals. Midli…

  PublisherOA PDFDOI

• Cognitive intra-individual variability dispersion as an emerging measure of neuropsychological inference: A narrative review of its history, methodology, empirical support, future directions, and recommendations for best practices

  2025-03-17 · 5 citations

  reviewOpen accessSenior author

  Objective: Cognitive intra-individual variability (IIV) is a commonly used method to estimate how dispersed or inconsistent an examinee’s test scores are across measures that comprise a test battery, trial-by-trial responses on a single task, or across multiple testing sessions. Elevated IIV has been hypothesized to reflect a failure of executive control due to alterations in brain activity or central nervous system integrity. Measures of IIV have a rich history. Growing empirical evidence suppo…

  PublisherDOI

• Precision Medicine Treatment of Alzheimer’s Disease: Successful Randomized Controlled Trial

  Preprints.org · 2026-04-20

  preprintOpen access

  Background: There is a critical need for effective therapeutics for Alzheimer’s. Personalized, precision medicine approaches represent a potentially effective strategy, and proof-of-concept trials have provided supportive data. Objective: To determine whether a precision medicine approach to Alzheimer’s at the mild cognitive impairment or early dementia stage is effective in a randomized controlled clinical trial. Methods: Seventy-three patients with mild cognitive impairment or early dementia w…

  PublisherDOI

Frequent coauthors

• Stephen L. Aita

  81 shared

• Nanako A Hawley

  University of South Alabama

  70 shared

• Jasmin H Pizer

  Boston University

  70 shared

• Vasilios C Ikonomou

  University of South Alabama

  66 shared

• Nicholas C. Borgogna

  Texas Tech University

  62 shared

• Tyler Owen

  Texas Tech University

  53 shared

• Erika C Pettway

  University of South Alabama

  52 shared

• Kyle M. Brasil

  University of South Alabama

  51 shared

Labs

• School of Professional StudiesPI

Education

• PhD, Psychology

  Louisiana State University

  2008

• MA, Psychology

  Wake Forest University

  2003

• BS, Psychology

  Coastal Carolina University

  1999

Similar researchers at Brown University

• David N. Weilh-77
• Kirsten Langdonh-32
• Liz Chenh-25